ONCOLOGY Vol 36, Issue 5

home / journals / oncology / oncology-vol-36-issue-5
Deciding Which Cancer-Related Fatigue Assessment Tool to Use Just Got Much Easier

Deciding Which Cancer-Related Fatigue Assessment Tool to Use Just Got Much Easier

Lisa Sprod, PhD, MPH
May 16th 2022
ArticlePerspective

Lisa Sprod, PhD, MPH, provides perspective on a cancer-related fatigue assessment tools.

Cancer-Related Fatigue Outcome Measures in Integrative Oncology: Evidence for Practice and Research Recommendations

Cancer-Related Fatigue Outcome Measures in Integrative Oncology: Evidence for Practice and Research Recommendations

Danielle Gentile, PhD;Dori Beeler, PhD;Xin Shelley Wang, MD, MPH;Eran Ben-Ayre, MD;Suzanna Maria Zick, ND, MPH;Ting Bao, MD, DABMA, MS;Linda E. Carlson, PhD;Ricardo Ghelman, MD, PhD;Viraj A. Master, MD, PhD;Debu Tripathy, MD;W. Iris Zhi, MD, PhD
May 16th 2022
ArticleReview Article

This review article written by Danielle Gentile, PhD, et al, reviews the management of cancer-related fatigue in integrative oncology.

Making Progress in PTCL: Significant Unmet Needs

Making Progress in PTCL: Significant Unmet Needs

Sunita D. Nasta, MD
May 13th 2022
ArticlePerspective

Sunita D. Nasta, MD, gives her perspective on emerging treatments for peripheral T-cell lymphomas.

Current Treatment of Peripheral T-cell Lymphoma

Current Treatment of Peripheral T-cell Lymphoma

Robert Stuver, MD;Zachary D. Epstein-Peterson, MD;William T. Johnson, DO;Niloufer Khan, MD, MS;Natasha Lewis, MD;Alison J. Moskowitz, MD;Craig S. Sauter, MD;Steven Horwitz, MD
May 13th 2022
ArticleReview Article

This review article written by Robert Stuver, MD, et al, reviews current and available treatments for peripheral T-cell lymphoma.

Leukocytoclastic Vasculitis Induced by Immune Checkpoint Inhibition in a Patient With Advanced Renal Cell Carcinoma

Leukocytoclastic Vasculitis Induced by Immune Checkpoint Inhibition in a Patient With Advanced Renal Cell Carcinoma

Justine Panian, BS;Elizabeth Pan, MD;Veronica Shi, MD;Brian Hinds, MD;Rana R. McKay, MD
May 11th 2022
ArticleClinical Quandaries

In this installment of Clinical Quandaries, Justine Panian, BS, and colleagues present a case of a 60-year-old Mexican woman with fevers, abdominal pain, and hypertension.

Expert Commentary On The Product Profile Of Dostarlimab

Expert Commentary On The Product Profile Of Dostarlimab

Megan May, PharmD, BCOP
May 10th 2022
ArticleInterview

In an interview with ONCOLOGY®, Megan May, PharmD, BCOP, offers a comprehensive review of real-world treatment considerations of dostarlimab as therapy for adult patients with recurrent or advanced solid tumors with deficient mismatch repair.

CRISPR Patent Battle: Beautiful Science, Poor Public Policy

CRISPR Patent Battle: Beautiful Science, Poor Public Policy

Howard S. Hochster, MD
May 10th 2022
ArticleEditorial

In this month's Letter to the Readers, ONCOLOGy co-editor-in-chief Howard Hochster, MD, reviews the implications of legal disputes surrounding patents for CRISPR technology.